Myriad Genetics Inc (MYGN)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 1,027,600 | 1,081,300 | 1,085,100 | 1,110,500 | 1,146,500 | 1,149,100 | 1,187,200 | 1,169,300 | 1,198,700 | 1,212,000 | 1,210,200 | 1,255,400 | 1,320,700 | 1,335,900 | 1,360,300 | 1,336,900 | 1,418,800 | 1,444,500 | 1,404,600 | 1,446,700 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,027,600K
= 0.00
The debt-to-assets ratio for Myriad Genetics Inc has consistently been 0.00 throughout the periods from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt financing to fund its assets during these periods. A debt-to-assets ratio of 0.00 suggests that the company's assets are entirely financed by equity, which may signify a lower financial risk due to the absence of debt obligations. However, it is important to note that a zero debt-to-assets ratio may also indicate missed opportunities for leveraging debt to potentially optimize the capital structure and improve returns for shareholders. Overall, a stable debt-to-assets ratio of 0.00 for Myriad Genetics Inc reflects a conservative financial approach with a relatively low level of leverage in its capital structure.
Peer comparison
Dec 31, 2024